1. Abstract
Background The use of long-term devices for chemotherapy in neoplastic diseases is very common. The CAVA trial was an extensive study that prospectively evaluated more than a thousand patients undergoing chemotherapy and randomized them to three groups: patients using PICC, Port or Hickmann-type catheters. For this study, a specific questionnaire was elaborated, called the Venous access device quality of life questionnaire (QolVAD), the aim of which is to assess the impact of the device (Hickmann type, PICC or thoracic Port) on the patients’ routine. However, there is no Brazilian – Portuguese version available, blunting its use in Brazilian patients.
Objective The objective of this study is to translate and validate de CAVA Trial QolVAD to the Brazilian – Portuguese, making possible its use in Brazilian population.
Methods One hundred sixty-seven patients with long term vascular access devices for chemotherapy participated in the study. After translation and retranslation, construct validity was analyzed by identifying correlation between QolVAD and European Quality of Life Questionnaire (EuroQol). To determine the reliability, internal consistency and test-retest with at least 7 days interval between 2 questionnaire applications were calculated.
Results The results showed a good internal and external consistency of the QolVAD. When comparing to EuroQol, significant correlations were found after comparing both questionnaires (r −0,658 and p < 0,001).
Conclusion The Brazilian – Portuguese version of the Quality-of-Life Vascular Access Device has presented good clinimetric properties and has shown to be applicable to the Brazilian population.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethicas committee of Hospital Israelita Albert Einstein gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
No disclosures. The authors declare that they have no conflicts of interest.
Title - revised Author affiliations updated
Data Availability
All data produced in the present study are available upon reasonable request to the authors